Skip to main content
Livermore
Livermore
ZHEN

Brooktree Capital Management

SEC CIK
0001021296
Latest filing
Aug 5, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Brooktree Capital Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
4,945
Value
$1.24M
% of portfolio
0.8%
Quarters held
20
Since Q1 2021
Holdings of ABBV by Brooktree Capital Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,945$1.24M0.8%−13−0.3%ReducedHolders
Q1 20264,958$1.08M0.9%00.0%UnchangedHolders
Q4 20254,958$1.13M0.8%00.0%UnchangedHolders
Q3 20254,958$1.15M0.7%00.0%UnchangedHolders
Q2 20254,958$920.3K0.6%+3,900+368.6%AddedHolders
Q1 20251,058$221.7K0.2%+1,058NewHolders
Q4 20240$00.0%−1,091−100.0%Sold outHolders
Q3 20241,091$215.5K0.2%+1,091NewHolders
Q2 20240$00.0%−1,130−100.0%Sold outHolders
Q1 20241,130$205.8K0.2%−3,517−75.7%ReducedHolders
Q4 20234,647$720.1K0.6%−106−2.2%ReducedHolders
Q3 20234,753$708.5K0.6%00.0%UnchangedHolders
Q2 20234,753$640.4K0.5%00.0%UnchangedHolders
Q1 20234,753$757.5K0.6%−3,742−44.0%ReducedHolders
Q4 20228,495$1.37M1.1%−1,050−11.0%ReducedHolders
Q3 20229,545$1.28M1.1%−211−2.2%ReducedHolders
Q2 20229,756$1.49M1.1%−1,816−15.7%ReducedHolders
Q1 202211,572$1.88M1.2%−3,383−22.6%ReducedHolders
Q4 202114,955$2.02M1.2%−1,011−6.3%ReducedHolders
Q3 202115,966$1.72M1.1%−912−5.4%ReducedHolders
Q2 202116,878$1.90M1.2%−73−0.4%ReducedHolders
Q1 202116,951$1.83M1.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.